Icu Medical (ICUI) 87.74 $ICUI
ICU Medical, Inc. Announces Time of First Quarter 2015 Earnings Call
GlobeNewswire - Tue Apr 21, 11:00AM CDT
ICU Medical, Inc., (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical devices used in infusion therapy, oncology and critical care applications, today announced the time of its first quarter 2015 earnings release conference call.
ICUI: 87.74 (-0.68)
ICU Medical Shares Up 42.0% Since SmarTrend's Buy Recommendation (ICUI)
Comtex SmarTrend(R) - Fri Apr 17, 9:49AM CDT
SmarTrend identified an Uptrend for ICU Medical (NASDAQ:ICUI) on August 12th, 2014 at $62.20. In approximately 8 months, ICU Medical has returned 42.04% as of today's recent price of $88.35.
ICUI: 87.74 (-0.68)
Uptrend Call Working As ICU Medical Stock Rises 47.8% (ICUI)
Comtex SmarTrend(R) - Fri Apr 10, 9:22AM CDT
SmarTrend identified an Uptrend for ICU Medical (NASDAQ:ICUI) on August 12th, 2014 at $62.20. In approximately 8 months, ICU Medical has returned 47.77% as of today's recent price of $91.91.
ICUI: 87.74 (-0.68)
Shares of ICUI Up 52.0% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Thu Apr 02, 5:10PM CDT
SmarTrend identified an Uptrend for ICU Medical (NASDAQ:ICUI) on August 12th, 2014 at $62.20. In approximately 8 months, ICU Medical has returned 51.99% as of today's recent price of $94.54.
ICUI: 87.74 (-0.68)
46.3% Return Seen to Date on SmarTrend ICU Medical Call (ICUI)
Comtex SmarTrend(R) - Thu Mar 26, 11:31AM CDT
SmarTrend identified an Uptrend for ICU Medical (NASDAQ:ICUI) on August 12th, 2014 at $62.20. In approximately 8 months, ICU Medical has returned 46.30% as of today's recent price of $91.00.
ICUI: 87.74 (-0.68)
Global Hemodynamic Monitoring System Market 2015-2019 - By Product, by Type & by End-User
M2 - Wed Mar 25, 10:25AM CDT
Research and Markets (http://www.researchandmarkets.com/research/ckqllp/hemodynamic) has announced the addition of the "Hemodynamic Monitoring System Market by Product (Systems and Disposables), by Type (Invasive, Minimally Invasive, Non-Invasive), by End-User (Hospitals, Cath Labs, Home and Ambulatory Sites) - Analysis & Global Forecast to 2019 " report to their offering. The global hemodynamic monitoring systems market is expected to reach $1,107.4 million in 2019 from $887.8 million in 2014, growing at a CAGR of 4.5%. The market is dominated by North America, followed by Europe, Asia, and Rest of the World (RoW). Asia is expected to grow at the fastest rate from 2014 to 2019. Hemodynamic monitoring systems are used to monitor blood pressure, cardiac output, and oxygenation of tissues and organs. The risks of infectious diseases associated with invasive hemodynamic monitoring have resulted in technological advancements such as development of minimally invasive and noninvasive technologies. The global hemodynamic monitoring systems market is segmented on the basis of products, types, end users, and regions. By product, the market is categorized into systems and disposables. In 2014, the disposables segment accounted for the largest share of the market. This segment is expected to grow at the fastest rate during the forecast period (2014 to 2019). On the basis of type, the hemodynamic monitoring systems market is divided into invasive, minimally invasive, and noninvasive systems. In 2014, the invasive systems segment accounted for the largest share of the market. However, the minimally invasive systems segment is expected to grow at the fastest rate during the forecast period. This market, by end user, is segmented into hospitals, cath labs, and home and ambulatory sites. The hospitals segment is the largest and fastest-growing market of the hemodynamic monitoring systems market. The key factors that are expected to spur the growth of this market are technological advancements in systems, increasing prevalence of hypertension and diabetes, and rapidly aging population. Moreover, rising aging population in the populous and emerging countries like India and China are likely to create huge opportunities for hemodynamic monitoring systems. However, risks associated with invasive hemodynamic monitoring are restraining the growth of this market. Key Topics Covered: 1 Introduction 2 Research Methodology 3 Executive Summary 4 Premium Insights 5 Market Overview 6 Industry Insights 7 Hemodynamic Monitoring System Market, By Product 8 Hemodynamic Monitoring System Market, By Type 9 Hemodynamic Monitoring System Market, By End User 10 Hemodynamic Monitoring System Market, By Geography 11 Competitive Landscape 12 Company Profiles - Cheetah Medical, Inc. - Deltex Medical Group PLC - Edwards Lifesciences Corporation - HEMO Sapiens, Inc. - ICU Medical, Inc. - Lidco Group PLC - Osypka Medical GMBH - Pulsion Medical Systems Se - Schwarzer Cardiotek GMBH - Tensys Medical, Inc. For more information visit http://www.researchandmarkets.com/research/ck...emodynamic
ICUI: 87.74 (-0.68), EW: 140.87 (+0.39)
Shares of ICUI Up 43.1% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Thu Mar 12, 9:33AM CDT
SmarTrend identified an Uptrend for ICU Medical (NASDAQ:ICUI) on August 12th, 2014 at $62.20. In approximately 7 months, ICU Medical has returned 43.09% as of today's recent price of $89.00.
ICUI: 87.74 (-0.68)
U.S. Cardiac Output Monitoring Market 2010-2020
M2 - Thu Feb 19, 2:07AM CST
Research and Markets (http://www.researchandmarkets.com/research/3st48p/u_s_cardiac) has announced the addition of the "U.S. Cardiac Output Monitoring Market" report to their offering. U.S. and European Cardiac Output Monitoring market report includes units sold, market value, forecasts, as well as detailed competitive market shares and analyses of major players' success strategies in each market and segment. This report includes elements of fetal antepartum monitoring and intrapartum monitoring as well as critical care and alternate care devices for premature infants. Scope: 2010-2020 Markets Covered: - Pulmonary Artery Catheter Market - Minimally Invasive Cardiac Output Monitoring Market - Non-Invasive Cardiac Output Monitoring Market Key Topics Covered: 1. Research Methodology 2. U.S. Cardiac Output Monitoring Market 2.1 Introduction 2.1.1 The Fick Principle 2.1.2 Dilution Methods 2.1.3 Doppler Echocardiography Ultrasound Methods 2.1.4 Pulse Pressure Methods 2.1.5 Other Methods 3. U.S. Cardiac Output Monitoring Market 3.1 Market Overview 3.2 Market Analysis And Forecast 3.3 Drivers And Limiters 3.4 Competitive Analysis 4. European Cardiac Output Monitoring Market 4.1 Market Overview 4.2 Market Analysis And Forecast 4.3 Drivers And Limiters 4.4 Competitive Analysis Companies Mentioned - CardioDynamics (SonoSite) - Cheetah Medical - Deltex Medical - Edwards Lifesciences - ICU Medical - LiDCO Cardiac Sensor Systems - Medis - Pulsion Medical For more information visit http://www.researchandmarkets.com/research/3s..._s_cardiac
ICUI: 87.74 (-0.68), EW: 140.87 (+0.39)
ICU Medical Has Returned 41.0% Since SmarTrend Recommendation (ICUI)
Comtex SmarTrend(R) - Wed Feb 18, 9:50AM CST
SmarTrend identified an Uptrend for ICU Medical (NASDAQ:ICUI) on August 12th, 2014 at $62.20. In approximately 6 months, ICU Medical has returned 40.98% as of today's recent price of $87.69.
ICUI: 87.74 (-0.68)
ICU's (ICUI) CEO Vivek Jain on Q4 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Mon Feb 09, 7:06PM CST
ICUI: 87.74 (-0.68)
ICU Medical posts 4Q profit
Automated Insights - Mon Feb 09, 4:58PM CST
SAN CLEMENTE, Calif. (AP) _ ICU Medical Inc. (ICUI) on Monday reported fourth-quarter net income of $7.4 million.
ICUI: 87.74 (-0.68)
Medtronic's Pipeline Flex Embolization Device Gets FDA Nod - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Feb 09, 4:05PM CST
Medtronic announced the FDA approval for its Pipeline Flex embolization device (the next-generation flow diversion device).
ICUI: 87.74 (-0.68), NXTM: 18.85 (+0.03), MDT: 78.01 (+0.93), ABAX: 63.25 (-0.09)
ICU Medical (ICUI) Q4 2014 Results - Earnings Call Webcast
SA Transcripts - at Seeking Alpha - Mon Feb 09, 3:25PM CST
ICUI: 87.74 (-0.68)
ICU Medical beats by $0.09, beats on revenue
Seeking Alpha - at Seeking Alpha - Mon Feb 09, 3:18PM CST
ICUI: 87.74 (-0.68)
ICU Medical, Inc. Announces Fourth Quarter and Fiscal Year 2014 Results
GlobeNewswire - Mon Feb 09, 3:11PM CST
ICU Medical, Inc., (Nasdaq:ICUI) ("ICU Medical"
, a leader in innovative medical devices used in vascular therapy, oncology and critical care applications, today announced financial results for the fourth quarter and fiscal year ended December 31, 2014.
ICUI: 87.74 (-0.68)
U.S. Market for Infusion Therapy Devices 2015 (Executive Summary)
M2 - Mon Feb 09, 9:08AM CST
Research and Markets (http://www.researchandmarkets.com/research/3jtjsm/u_s_market_for) has announced the addition of the "U.S. Market for Infusion Therapy Devices 2015 (Executive Summary)" report to their offering. This market includes infusion pumps, intravenous (IV) sets, and needleless connectors (NLCs). The infusion pump market is further divided into segments for large volume, syringe, patient-controlled analgesia (PCA), electronic ambulatory and disposable ambulatory infusion pumps. Main Markets Covered: - Infusion Pump Market - Intravenous Set Market - Needleless Connector Market - Anti-reflux neutral displacement needleless connectors Companies Mentioned - B. Braun - Baxter International - Carefusion - Hospira - ICU Medical - Smiths Medical For more information visit http://www.researchandmarkets.com/research/3j...market_for
ICUI: 87.74 (-0.68), BAX: 70.38 (+0.33)
Notable earnings after Monday’s close
Seeking Alpha - at Seeking Alpha - Sun Feb 08, 4:35PM CST
CCK: 54.75 (+0.19), MXL: 8.61 (+0.07), TDW: 24.66 (-0.59), MOH: 63.02 (-0.71), DAC: 6.24 (+0.11), PRI: 47.88 (-0.67), ICUI: 87.74 (-0.68), NEWP: 20.51 (+0.10), CSC: 65.83 (+0.77), GSM: 20.46 (-0.43), QLYS: 52.38 (-0.77), AMAG: 57.68 (+0.47), AMKR: 8.47 (+0.17), NTES: 114.64 (-0.59), IPHI: 19.18 (+0.25), GIG: 1.46 (+0.06), ALSN: 32.31 (+0.26), KS: 28.33 (+0.21), SSNI: 10.01 (+0.21), CMP: 88.49 (-0.62), COUP: 13.11 (+0.33), MRH: 39.05 (+0.03), NBIX: 43.23 (-0.43), MODN: 12.21 (-0.04), RLD: 12.59 (+0.02), DNB: 132.31 (+0.17), WCN: 46.08 (-0.09), MCC: 9.10 (+0.11), CRK: 4.52 (+0.05), OTTR: 31.42 (-0.21), MERU: 1.30 (unch)
CareFusion Q2 Earnings & Revenues Top Estimates, Up Y/Y - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Feb 06, 8:22AM CST
CareFusion Corporation's (CFN) second-quarter fiscal 2015 EPS surged nearly 83.3% on a year-over-year basis driven by strong revenue growth.
ICUI: 87.74 (-0.68), BDX: 144.33 (-1.24), ABAX: 63.25 (-0.09), CFN: 59.91 (-0.06)
ICU Medical, Inc. Announces Time of First Quarter 2015 Earnings Call
GlobeNewswire - Tue Apr 21, 11:00AM CDT
ICU Medical, Inc., (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical devices used in infusion therapy, oncology and critical care applications, today announced the time of its first quarter 2015 earnings release conference call.
ICUI: 87.74 (-0.68)
ICU Medical Shares Up 42.0% Since SmarTrend's Buy Recommendation (ICUI)
Comtex SmarTrend(R) - Fri Apr 17, 9:49AM CDT
SmarTrend identified an Uptrend for ICU Medical (NASDAQ:ICUI) on August 12th, 2014 at $62.20. In approximately 8 months, ICU Medical has returned 42.04% as of today's recent price of $88.35.
ICUI: 87.74 (-0.68)
Uptrend Call Working As ICU Medical Stock Rises 47.8% (ICUI)
Comtex SmarTrend(R) - Fri Apr 10, 9:22AM CDT
SmarTrend identified an Uptrend for ICU Medical (NASDAQ:ICUI) on August 12th, 2014 at $62.20. In approximately 8 months, ICU Medical has returned 47.77% as of today's recent price of $91.91.
ICUI: 87.74 (-0.68)
Shares of ICUI Up 52.0% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Thu Apr 02, 5:10PM CDT
SmarTrend identified an Uptrend for ICU Medical (NASDAQ:ICUI) on August 12th, 2014 at $62.20. In approximately 8 months, ICU Medical has returned 51.99% as of today's recent price of $94.54.
ICUI: 87.74 (-0.68)
46.3% Return Seen to Date on SmarTrend ICU Medical Call (ICUI)
Comtex SmarTrend(R) - Thu Mar 26, 11:31AM CDT
SmarTrend identified an Uptrend for ICU Medical (NASDAQ:ICUI) on August 12th, 2014 at $62.20. In approximately 8 months, ICU Medical has returned 46.30% as of today's recent price of $91.00.
ICUI: 87.74 (-0.68)
Global Hemodynamic Monitoring System Market 2015-2019 - By Product, by Type & by End-User
M2 - Wed Mar 25, 10:25AM CDT
Research and Markets (http://www.researchandmarkets.com/research/ckqllp/hemodynamic) has announced the addition of the "Hemodynamic Monitoring System Market by Product (Systems and Disposables), by Type (Invasive, Minimally Invasive, Non-Invasive), by End-User (Hospitals, Cath Labs, Home and Ambulatory Sites) - Analysis & Global Forecast to 2019 " report to their offering. The global hemodynamic monitoring systems market is expected to reach $1,107.4 million in 2019 from $887.8 million in 2014, growing at a CAGR of 4.5%. The market is dominated by North America, followed by Europe, Asia, and Rest of the World (RoW). Asia is expected to grow at the fastest rate from 2014 to 2019. Hemodynamic monitoring systems are used to monitor blood pressure, cardiac output, and oxygenation of tissues and organs. The risks of infectious diseases associated with invasive hemodynamic monitoring have resulted in technological advancements such as development of minimally invasive and noninvasive technologies. The global hemodynamic monitoring systems market is segmented on the basis of products, types, end users, and regions. By product, the market is categorized into systems and disposables. In 2014, the disposables segment accounted for the largest share of the market. This segment is expected to grow at the fastest rate during the forecast period (2014 to 2019). On the basis of type, the hemodynamic monitoring systems market is divided into invasive, minimally invasive, and noninvasive systems. In 2014, the invasive systems segment accounted for the largest share of the market. However, the minimally invasive systems segment is expected to grow at the fastest rate during the forecast period. This market, by end user, is segmented into hospitals, cath labs, and home and ambulatory sites. The hospitals segment is the largest and fastest-growing market of the hemodynamic monitoring systems market. The key factors that are expected to spur the growth of this market are technological advancements in systems, increasing prevalence of hypertension and diabetes, and rapidly aging population. Moreover, rising aging population in the populous and emerging countries like India and China are likely to create huge opportunities for hemodynamic monitoring systems. However, risks associated with invasive hemodynamic monitoring are restraining the growth of this market. Key Topics Covered: 1 Introduction 2 Research Methodology 3 Executive Summary 4 Premium Insights 5 Market Overview 6 Industry Insights 7 Hemodynamic Monitoring System Market, By Product 8 Hemodynamic Monitoring System Market, By Type 9 Hemodynamic Monitoring System Market, By End User 10 Hemodynamic Monitoring System Market, By Geography 11 Competitive Landscape 12 Company Profiles - Cheetah Medical, Inc. - Deltex Medical Group PLC - Edwards Lifesciences Corporation - HEMO Sapiens, Inc. - ICU Medical, Inc. - Lidco Group PLC - Osypka Medical GMBH - Pulsion Medical Systems Se - Schwarzer Cardiotek GMBH - Tensys Medical, Inc. For more information visit http://www.researchandmarkets.com/research/ck...emodynamic
ICUI: 87.74 (-0.68), EW: 140.87 (+0.39)
Shares of ICUI Up 43.1% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Thu Mar 12, 9:33AM CDT
SmarTrend identified an Uptrend for ICU Medical (NASDAQ:ICUI) on August 12th, 2014 at $62.20. In approximately 7 months, ICU Medical has returned 43.09% as of today's recent price of $89.00.
ICUI: 87.74 (-0.68)
U.S. Cardiac Output Monitoring Market 2010-2020
M2 - Thu Feb 19, 2:07AM CST
Research and Markets (http://www.researchandmarkets.com/research/3st48p/u_s_cardiac) has announced the addition of the "U.S. Cardiac Output Monitoring Market" report to their offering. U.S. and European Cardiac Output Monitoring market report includes units sold, market value, forecasts, as well as detailed competitive market shares and analyses of major players' success strategies in each market and segment. This report includes elements of fetal antepartum monitoring and intrapartum monitoring as well as critical care and alternate care devices for premature infants. Scope: 2010-2020 Markets Covered: - Pulmonary Artery Catheter Market - Minimally Invasive Cardiac Output Monitoring Market - Non-Invasive Cardiac Output Monitoring Market Key Topics Covered: 1. Research Methodology 2. U.S. Cardiac Output Monitoring Market 2.1 Introduction 2.1.1 The Fick Principle 2.1.2 Dilution Methods 2.1.3 Doppler Echocardiography Ultrasound Methods 2.1.4 Pulse Pressure Methods 2.1.5 Other Methods 3. U.S. Cardiac Output Monitoring Market 3.1 Market Overview 3.2 Market Analysis And Forecast 3.3 Drivers And Limiters 3.4 Competitive Analysis 4. European Cardiac Output Monitoring Market 4.1 Market Overview 4.2 Market Analysis And Forecast 4.3 Drivers And Limiters 4.4 Competitive Analysis Companies Mentioned - CardioDynamics (SonoSite) - Cheetah Medical - Deltex Medical - Edwards Lifesciences - ICU Medical - LiDCO Cardiac Sensor Systems - Medis - Pulsion Medical For more information visit http://www.researchandmarkets.com/research/3s..._s_cardiac
ICUI: 87.74 (-0.68), EW: 140.87 (+0.39)
ICU Medical Has Returned 41.0% Since SmarTrend Recommendation (ICUI)
Comtex SmarTrend(R) - Wed Feb 18, 9:50AM CST
SmarTrend identified an Uptrend for ICU Medical (NASDAQ:ICUI) on August 12th, 2014 at $62.20. In approximately 6 months, ICU Medical has returned 40.98% as of today's recent price of $87.69.
ICUI: 87.74 (-0.68)
ICU's (ICUI) CEO Vivek Jain on Q4 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Mon Feb 09, 7:06PM CST
ICUI: 87.74 (-0.68)
ICU Medical posts 4Q profit
Automated Insights - Mon Feb 09, 4:58PM CST
SAN CLEMENTE, Calif. (AP) _ ICU Medical Inc. (ICUI) on Monday reported fourth-quarter net income of $7.4 million.
ICUI: 87.74 (-0.68)
Medtronic's Pipeline Flex Embolization Device Gets FDA Nod - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Feb 09, 4:05PM CST
Medtronic announced the FDA approval for its Pipeline Flex embolization device (the next-generation flow diversion device).
ICUI: 87.74 (-0.68), NXTM: 18.85 (+0.03), MDT: 78.01 (+0.93), ABAX: 63.25 (-0.09)
ICU Medical (ICUI) Q4 2014 Results - Earnings Call Webcast
SA Transcripts - at Seeking Alpha - Mon Feb 09, 3:25PM CST
ICUI: 87.74 (-0.68)
ICU Medical beats by $0.09, beats on revenue
Seeking Alpha - at Seeking Alpha - Mon Feb 09, 3:18PM CST
ICUI: 87.74 (-0.68)
ICU Medical, Inc. Announces Fourth Quarter and Fiscal Year 2014 Results
GlobeNewswire - Mon Feb 09, 3:11PM CST
ICU Medical, Inc., (Nasdaq:ICUI) ("ICU Medical"
, a leader in innovative medical devices used in vascular therapy, oncology and critical care applications, today announced financial results for the fourth quarter and fiscal year ended December 31, 2014. ICUI: 87.74 (-0.68)
U.S. Market for Infusion Therapy Devices 2015 (Executive Summary)
M2 - Mon Feb 09, 9:08AM CST
Research and Markets (http://www.researchandmarkets.com/research/3jtjsm/u_s_market_for) has announced the addition of the "U.S. Market for Infusion Therapy Devices 2015 (Executive Summary)" report to their offering. This market includes infusion pumps, intravenous (IV) sets, and needleless connectors (NLCs). The infusion pump market is further divided into segments for large volume, syringe, patient-controlled analgesia (PCA), electronic ambulatory and disposable ambulatory infusion pumps. Main Markets Covered: - Infusion Pump Market - Intravenous Set Market - Needleless Connector Market - Anti-reflux neutral displacement needleless connectors Companies Mentioned - B. Braun - Baxter International - Carefusion - Hospira - ICU Medical - Smiths Medical For more information visit http://www.researchandmarkets.com/research/3j...market_for
ICUI: 87.74 (-0.68), BAX: 70.38 (+0.33)
Notable earnings after Monday’s close
Seeking Alpha - at Seeking Alpha - Sun Feb 08, 4:35PM CST
CCK: 54.75 (+0.19), MXL: 8.61 (+0.07), TDW: 24.66 (-0.59), MOH: 63.02 (-0.71), DAC: 6.24 (+0.11), PRI: 47.88 (-0.67), ICUI: 87.74 (-0.68), NEWP: 20.51 (+0.10), CSC: 65.83 (+0.77), GSM: 20.46 (-0.43), QLYS: 52.38 (-0.77), AMAG: 57.68 (+0.47), AMKR: 8.47 (+0.17), NTES: 114.64 (-0.59), IPHI: 19.18 (+0.25), GIG: 1.46 (+0.06), ALSN: 32.31 (+0.26), KS: 28.33 (+0.21), SSNI: 10.01 (+0.21), CMP: 88.49 (-0.62), COUP: 13.11 (+0.33), MRH: 39.05 (+0.03), NBIX: 43.23 (-0.43), MODN: 12.21 (-0.04), RLD: 12.59 (+0.02), DNB: 132.31 (+0.17), WCN: 46.08 (-0.09), MCC: 9.10 (+0.11), CRK: 4.52 (+0.05), OTTR: 31.42 (-0.21), MERU: 1.30 (unch)
CareFusion Q2 Earnings & Revenues Top Estimates, Up Y/Y - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Feb 06, 8:22AM CST
CareFusion Corporation's (CFN) second-quarter fiscal 2015 EPS surged nearly 83.3% on a year-over-year basis driven by strong revenue growth.
ICUI: 87.74 (-0.68), BDX: 144.33 (-1.24), ABAX: 63.25 (-0.09), CFN: 59.91 (-0.06)
